Streetbeat News

Earnings

LZ

LegalZoom has projected its Q3 revenue to be between $159M and $161M, which is in line with the estimated $159.61M. The company also expects its EBITDA to be between $26M and $28M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:36 pm

GTBIF

Green Thumb Industries (OTC:GTBIF) reported Q2 earnings of $0.05 per share, meeting analyst consensus. This is a 50% decrease from the same period last year. The company's quarterly sales of $252.39M beat the analyst consensus estimate of $250.56M by 0.73%, but it's a 0.76% decrease from last year's sales.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 8:36 pm

GRWG

GrowGeneration reported Q2 losses of $(0.09) per share, missing the analyst consensus estimate of $(0.08) by 12.5%. The company's quarterly sales were $63.92 million, missing the analyst consensus estimate of $64.98 million by 1.62%. This represents a 35.71% increase in losses and a 10.08% decrease in sales compared to the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 08, 2023 | 8:36 pm

ATRA

Atara Biotherapeutics reported Q2 losses of $(0.68) per share, missing the analyst consensus estimate of $(0.67) by 1.49%. This is a 119.35% decrease from the same period last year. The company also reported quarterly sales of $957.00K, missing the analyst consensus estimate of $3.77M by 74.62%. This is a 98.14% decrease from the same period last year.

Portfolio Pulse from mahesh@benzinga.com

August 08, 2023 | 8:36 pm

LILA

Liberty Latin America (NASDAQ:LILA) reported Q2 sales of $1.12 billion, missing the analyst consensus estimate of $1.14 billion by 1.49 percent. This represents a 7.80 percent decrease compared to the same period last year.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 8:35 pm

ACCO

ACCO Brands has projected its Q3 adjusted EPS to be between $0.21 and $0.24, which is lower than the estimated $0.30.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:35 pm

BODY

Beachbody Co (NYSE:BODY) reported Q2 losses of $(0.08) per share, beating the analyst consensus estimate of $(0.09) by 11.11%. However, the company's quarterly sales of $134.95 million missed the analyst consensus estimate of $136.26 million by 0.96%. This represents a 24.67% decrease in sales compared to the same period last year.

Portfolio Pulse from totan@benzinga.com

August 08, 2023 | 8:35 pm

EBS

Emergent BioSolutions (NYSE:EBS) reported Q2 losses of $(1.06) per share, missing the analyst consensus estimate of $(0.47) by 125.53%. This is a 23.26% decrease over losses from the same period last year. However, the company reported quarterly sales of $337.90 million, beating the analyst consensus estimate of $217.03 million by 55.69%, a 39.23% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 8:34 pm

CPIX

Cumberland Pharmaceuticals (NASDAQ:CPIX) reported Q2 earnings of $0.16 per share, a 1700% increase YoY. The company also reported a 5.73% increase in sales to $10.89 million YoY.

Portfolio Pulse from bharat@benzinga.com

August 08, 2023 | 8:34 pm

TDUP

ThredUp (NASDAQ:TDUP) reported Q2 earnings per share of $(0.18), beating the analyst consensus estimate of $(0.23) by 21.74%. This is a 37.93% increase over losses from the same period last year. The company also reported quarterly sales of $82.66 million, beating the analyst consensus estimate of $81.14 million by 1.87%. This is an 8.16% increase over sales from the same period last year.

Portfolio Pulse from totan@benzinga.com

August 08, 2023 | 8:34 pm